On the other hand, in patients with chronic heart failure, the profound upregulation of vasoconstrictor substances such as angiotensin II, endothelin-1, and norepinephrine may explain the relatively preserved compensatory vasoconstriction observed in this group in our study [19]. The gene discussed is EDN1; the disease is congestive heart failure.